Back to search results

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

Abroad (travel likely)RecruitingPHASE1

Conditions

B-Cell Leukemia · Non-Hodgkin's Lymphoma · B-cell Acute Lymphoblastic Leukemia · Diffuse Large B Cell Lymphoma · High-grade B-cell Lymphoma · Primary Mediastinal Large B-cell Lymphoma (PMBCL) · Mantle Cell Lymphoma · B-cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada

    Contact: Study coordinator (Oluwaponmile Odukoya) · oluwaponmile.odukoya@albertahealthservices.ca
    Contact: Principal Investigator (Robert Puckrin, MD)

  • Alberta Children's Hospital, Calgary, Alberta, Canada

    Contact: Study coordinator (Sherry Qian) · sherry.qian@albertahealthservices.ca
    Contact: Principal Investigator (Victor Lewis, MD)

  • Vancouver General Hospital, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Madeleine Cannings) · madeleine.cannings@bccancer.bc.ca
    Contact: Principal Investigator (Hannah Cherniawsky, MD)

  • BC Children's Hospital, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Nima Molavi) · nima.molavi@cw.bc.ca
    Contact: Principal Investigator (Amanda Li, MD)

  • The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada

    Contact: Study coordinator (Vanessa Lopez) · vlopez@ohri.ca
    Contact: Principal Investigator (Natasha Kekre, MD)
    Harold Atkins, MD (Sub-investigator)

  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

    Contact: Study coordinator (Aidan Shair) · aidan.shair@uhn.ca
    Contact: Principal Investigator (John Kuruvilla, MD)

  • The Hospital for Sick Children, Toronto, Ontario, Canada

    Contact: Study coordinator (Erilda Kapllani) · erilda.kapllani@sickkids.ca
    Contact: Principal Investigator (Joerg Krueger, MD)
Study leads

  • Kevin Hay, MD

    Principal Investigator

    BC Cancer

View source on ClinicalTrials.gov(opens in a new tab)